title: Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog.
authors.forename: Siegrid S
authors.initials: SS
authors.lastname: Yu
authors.forename: M Kari
authors.initials: MK
authors.lastname: Connolly
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Berger
authors.forename: Timothy H
authors.initials: TH
authors.lastname: McCalmont
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D003874:Dermatitis Herpetiformis / Q000139:chemically induced*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide